iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
Doctors do not use one universal “after immunotherapy” schedule. For metastatic colorectal cancer, the interval depends on whether treatment is still active, how long immune checkpoint inhibitor (ICI) treatment has continued, the tumour’s mismatch-repair status, and whether the person has had potentially curative surgery.
Current European guidance recommends CT or MRI-based reassessment with carcinoembryonic antigen (CEA) during active treatment, usually every 8–12 weeks. For a specific group—people with deficient mismatch repair or high microsatellite instability (dMMR/MSI-H) tumours who still have a response or stable disease after two years of ICIs and no serious adverse events—the recommended interval is CEA and radiological assessment every three to six months. These are oncology-team plans, not rules that apply to every bowel-cancer survivor.
The monitoring schedules doctors use
“Bowel cancer” is the everyday term; clinical guidelines generally say colorectal cancer, covering cancers of the colon and rectum. The table below separates the settings that are often confused when people ask, “How often will I have scans after immunotherapy?”
Quick wins for a faster PC:
Repair Windows errors before they cause bigger problemsFix Now →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Clear out junk files and repair common Windows errorsFree Scan →| Clinical situation | What is monitored | Interval or time frame | Where the recommendation comes from |
|---|---|---|---|
| Metastatic colorectal cancer while treatment is active | Radiological assessment, usually CT or MRI, plus CEA | Every 8–12 weeks | ESMO 2026 guideline |
| dMMR/MSI-H metastatic disease after two years of ICIs, with ongoing response or stable disease and no serious adverse events | Radiological assessment and CEA | Every 3–6 months | ESMO 2026 guideline |
| Non-metastatic colorectal cancer after potentially curative surgery | Serum CEA and CT of the chest, abdomen and pelvis, with colonoscopy in the postoperative pathway | Follow-up for the first three years; CEA at least every six months, at least two CT scans in those three years, and clearance colonoscopy within one year of diagnosis | NICE NG151 and NICE quality standard |
| KEYNOTE-177 clinical trial of pembrolizumab for MSI-H/dMMR metastatic disease | CT imaging of the chest, abdomen and pelvis to measure tumour response | Response assessed at week 9 and every nine weeks afterwards in the trial protocol | KEYNOTE-177 final analysis |
The postoperative NICE schedule is for people treated with potentially curative surgery for non-metastatic disease. It should not be transferred automatically to someone whose metastatic cancer is responding to immunotherapy, and a clinical-trial timetable is not a routine-care prescription.
#1 Best Overall
- Powerful Turbo Fan:CAGIWIRU Electric Air Duster have reached speed up to 130000RPM,Can efficient remove dust and debris.With LED light and Three Adjustable Speed to meet with different cleaning tasks.
- With Attached USB C Fasting Charging cable.Charing 3 hours,Enjoy up to 240 minutes of use on the lowest setting, For third speed can use for 25mins.with four charging options to meet with your needs.
- Wide Application: attached 5 different nozzles,making it suitable for a variety of scenes, such as car,pet, pc, keyboards, and other electronic devices. It also serves for office and home clean duster.
- Handy Design & Portable:Cordless air duster electric nozzle is Light weight and small size, design and comfortable to hold and space saving, convenient to carry around. You can put it in your room or inside the car without taking up space.
- Economical &Reusable: Built durable materials with a long-lasting battery,our CAGIWIRU air duster it's a sustainable alternative to disposable air cans.
What doctors check at each follow-up
Scans show where the known cancer stands
CT or MRI lets the oncology team compare current disease with earlier images. They look for shrinkage, stability, new lesions or progression, and for changes at the sites that were involved when treatment began. The exact modality depends on the organs involved, the quality of previous images, kidney function, contrast considerations and local practice. A scan is an assessment of disease status; it does not by itself prove that every cancer cell has gone.
CEA adds a blood-based trend
Carcinoembryonic antigen (CEA) is a tumour marker that ESMO places alongside imaging for active metastatic treatment and for the defined post-two-year ICI group. Doctors interpret a result against earlier values, the scan and the patient’s clinical picture. CEA can be normal even when colorectal cancer is present, and it can rise for reasons unrelated to cancer, so a single result is not a stand-alone detector of recurrence or a definitive measure of response.
Symptoms, examination and treatment effects complete the picture
An appointment also gives the team a chance to ask about pain, bowel or urinary changes, weight, breathing, fatigue, neurological symptoms and general function, and to examine the patient when appropriate. Immunotherapy can cause inflammatory adverse effects in organs such as the bowel, liver, lungs, thyroid and other endocrine glands. The sources cited here do not establish one universal timetable for every symptom review or laboratory test after response; the treating team sets those details around the drugs used and the person’s health.
Recommended Free Tools
During active immunotherapy for metastatic disease
When metastatic colorectal cancer is still being treated, ESMO’s 2026 guidance recommends reassessment every 8–12 weeks, usually combining CT or MRI with CEA. The purpose is to decide whether the cancer is responding, remaining stable, progressing or requiring a change in treatment. “Every 8–12 weeks” is a clinical window rather than a promise that every scan will occur on an identical day.
Rank #2
- Screen Cleaner is Your Screen’s New Bestfriend! - EVEO is proud to present a screen cleaner that’s perfectly suited for your TV. Meet your new screen cleaner, computer screen cleaner, laptop cleaner, iPad cleaner, Macbook,tv cleaner or any other electronic device. Our screen cleaner spray and wipe along with the included plush microfiber cloth, easily removes dust, fingerprints & other smudges on the screen’s surface. Clean effectively for a streak-free screen
- Gentle on your Screens - Our screen cleaner spray and wipes is compatible to be used even for the most sensitive LCD, LED, CRT, and OLED screens in proper use. Be at ease knowing that this product is compatible with all the major brands: LG, SONY, Samsung, Sharp, iPad, iPhone, Android screens, Kindle, PC monitors - we’ve got you covered! Can be used as LCD screen cleaner, tv cleaner, smart tv screen cleaner, and more
- Premium Super Soft Plush Microfiber Cloth - Included in this efficient screen cleaning kit. This screen cleaner spray and wipe has our signature plush microfiber cloth specially designed to comply with screens and monitors and leave them streak-free. Has been shown to effectively absorbs stubborn stains, zero streaks, and no fiber shedding. Always use this together with our screen cleaner for the best results
- Easy-to-Use Screen Cleaner Kit + microfiber cleaning cloth - The EVEO Screen Cleaning Kit will easily be your new favorite tool when it comes to taking care of the things you love most, quick and easy solution for a streak-free screen. Simply screw on the sprayer gun on the screen cleaner bottle. Spray the cleaning liquid onto the microfiber cloth, then wipe the screen until desired cleanliness & shine is achieved.
- Quality Screen Care Kit Worth Purchasing - Enjoy a convenient Screen Cleaner anytime, anywhere you need it. Your satisfaction is our top priority. We stand behind the quality of our products and that’s why, you shouldn’t be worrying at all. We manufacture the Best Screen Cleaner. and can be used for laptop cleaning kit, laptop screen cleaner, tv screen cleaner for smart tv. MacBook screen cleaner, monitor cleaner or screen cleaner spray for electronic devices with microfiber cleaning cloth
The interval can shift for practical and clinical reasons, such as a recent hospitalisation, a treatment delay, a need to investigate a new symptom or the time required to clarify an indeterminate scan. Patients should ask whether a planned scan is a routine response assessment or an urgent investigation; those are different decisions even when the same imaging machine is used.
After two years of an immune checkpoint inhibitor
For dMMR or MSI-H metastatic tumours, ESMO states: “Patients with dMMR or MSI-H tumours with ongoing response or stable disease after 2 years of ICIs with no serious AEs should undergo CEA and radiological assessments every 3-6 months.” The recommendation applies only when all of those conditions are met: the tumour biology is dMMR/MSI-H, the person has completed two years of ICI therapy, disease is still responding or stable, and there have been no serious adverse events.
This is a less frequent interval than the usual active-treatment reassessment window because it addresses a different treatment moment. It does not mean that immunotherapy has necessarily ended, that monitoring can stop, or that every patient with a good scan qualifies. The oncologist may continue, pause or stop treatment according to the regimen, response, toxicity and the overall treatment plan, then arrange imaging and CEA at an interval within the recommended range.
Do these 3 things before closing this tab:
1Fix the driver behind crashes, sound loss and screen glitches2Clear out junk files and repair common Windows errors3Scan for outdated or missing drivers - takes under a minuteWhat may happen if immunotherapy stops
Stopping an ICI for reasons other than documented progression does not create a single universally specified scan calendar in the material cited here. A pembrolizumab phase III protocol describes continued radiological monitoring after treatment stopped for reasons other than progression and repeat imaging to confirm apparent progression in participants who were clinically stable. Those are trial procedures, not a blanket rule for routine care; the protocol is available through ClinicalTrials.gov.
Rank #3
- 【Large size】：Measuring 800 x 300 mm/ 31. 5×12 inches, which is wider and taller than others. Large mouse pad can perfectly fit your keyboard and mouse of any size, and there is also ample space for peripherals such as phones, tablets, etc.
- 【LED backlight mouse pad】：Blade Hawks RGB mouse pad provides 7 static modes and 7 dynamic modes will give you the options you are looking for. Power-off memory function remembers the last lighting mode you selected. The super glow fiber Chroma will give you a colorful gaming setup that you want.
- 【Anti-slip rubber base】：Made from Natural rubber, this gaming mousepad will firmly grip your desktop, allowing you to enjoy the ultimate precision in the games you are most passionate about. It also comes with a texture that enhances this ability even further.
- 【Smooth and waterproof surface】: Micro-textured cloth surface, for extremely precise mouse control and a smooth movement. When liquid splashes on the gaming mouse pad, it forms water droplets and slides down. Will not delay your work or gameplay.
- 【Plug and play】: This mouse and keyboard pad is powered by USB, plug and play, no driver required. One button control light modes. Press one time to change the lighting mode, press twice to change the brightness, press and hold about 3 seconds turn ON/OFF.
The practical plan after stopping therefore depends on why treatment stopped, the amount and location of residual disease, the previous scan pattern, CEA results, prior surgery or ablation and the patient’s symptoms. The oncology team should state what the next scan is intended to establish and what finding would change management.
Why surgery changes the follow-up pathway
A person whose non-metastatic colorectal cancer has been removed with potentially curative surgery follows a different surveillance pathway from someone with unresected metastatic disease responding to an ICI. NICE recommends follow-up during the first three years, including serum CEA and CT of the chest, abdomen and pelvis. Its quality statement specifies CEA at least every six months, a minimum of two CT scans during those three years and a clearance colonoscopy within a year of diagnosis.
That schedule is designed to detect local recurrence, distant metastases or a new lesion after curative-intent treatment. It is not evidence that an individual with metastatic cancer should receive exactly two CT scans in three years, nor that a patient who has responded to immunotherapy no longer needs the metastatic-disease assessments described by ESMO.
The Tool Desk
Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →What clinical trials can—and cannot—tell you
KEYNOTE-177, a phase III trial in MSI-H/dMMR metastatic colorectal cancer, assessed response with CT of the chest, abdomen and pelvis at week 9 and every nine weeks thereafter. The schedule explains how researchers measured outcomes under a controlled protocol; it is not a universal routine-care interval.
Rank #4
- 【Softer and More Comfortable】Vaydeer wrist rest has unique diamond pattern, which is the combination of softness and aesthetics. The materials of wrist rest are improved into higher quality memory foam and covered with silky smooth lycra. The computer wrist rest makes you as comfortable and cushiony as like rest your wrists on clouds.
- 【Ergonomic Wrist Saver】The wrist rests for keyboard and mouse comes with a 17.32×3.15×0.83 inch keyboard wrist pad and a 5.94×3.15×0.83 inch mouse wrist support. Based on ergonomic design, the unique concave shape is the perfect fit for your wrist joints. The wrist rest pad fits most computer keyboards and laptops, improve hand and wrist posture, release your wrist and arm stress.
- 【Non-Slip Rubber Bottom】Featuring an anti-skid silicone base on the bottom, this wrist keyboard support stays firmly in place on your desk, preventing the padding from sliding around, ensuring stable and consistent wrist support during extended computer sessions.
- 【Better Experience & Pain Relief】Our keyboard arm rest is beneficial to alleviate the soreness caused by direct contact and friction between your arm and a hard desk surface, reducing the risk of wrist fatigue or carpal tunnel. The soft texture of memory foam can evenly distribute the pressure around your wrists and provide good support with just enough give.
- 【Helpful in Multiple Scenarios】Whether you're working, studying, writing, typing, gaming, this keyboard and mouse rest combo is an essential accessory to add comfort and support to your hands and wrists. It’s also a great gift for men, women, family, friend, coworker, gamer, teacher, etc.
The trial’s five-year follow-up reported durable responses in its study population, as recorded in the 2025 Annals of Oncology report. Durable response is an important reason to keep follow-up in place, but that report does not establish one surveillance interval for everyone after treatment ends. Trial participants also had eligibility criteria, scheduled assessments and management rules that may not match an individual patient’s situation.
Does a clear scan mean the cancer is cured?
No. A complete radiological response means that currently used imaging does not show measurable cancer in the assessed areas. It does not prove that microscopic disease is absent, and it does not predict the future with certainty. CEA can support the interpretation but cannot certify cure either. Continued appointments are used to detect a change early, monitor delayed treatment effects and reassess health even when scans remain clear.
The meaning of “clear” also depends on the starting point. A person with metastatic disease may have no visible lesions after treatment yet still require metastatic-disease surveillance. Someone who had non-metastatic cancer removed surgically may be following the NICE postoperative pathway. Asking which disease setting the doctor is using prevents a reassuring scan from being interpreted as a promise that follow-up is finished.
How your oncologist chooses the interval
Guideline windows are adapted to the individual. The team considers:
Best Value
- 【No Drill Mounted】Cable management tray can be assembled in as little as 3 minutes or less-simply. Side clips easily clampe the edge of desk, pass through the holes on the sides, and secure excess cables with baskets. Desk cable management supports inward or outward installation to meet your needs in different scenarios, and provides you with great convenience when collecting and organizing wires.
- 【Rubber Pad Protects Desk】Wire organizer under desk built-in soft rubber pads on the clamp protect your desk from scratches, so you will not damage your furniture or office.
- 【Sturdy and Beautiful】Cord management under desk is made of high-quality carbon steel and holds about 15 lbs. The wire basket has 2 holes on each side of the tray to enable your cables to pass freely. Cable baskets are suitable for desk thickness use from 0.4" to 2.4".
- 【Space Saving & Keep Organized】Desk cable management tray holds all your power cords, outlet strips, USB hubs and computer transformers hidden from your feet, and the data cables will not enter the vacuum cleaner to keep your desk clean and tidy. Desk wire organizer is also suitable for use in the kitchen and outdoors.
- 【Reduce Safety Risks】Cable tray under desk keeps all plugs away from your kids, no more worry about tripping. Using 2 holes wire tray saves extra space, helps you easily cabling and wire protection. The mesh design is not easy to accumulate dust, but avoids safety accidents caused by messy wires.
- Whether disease is metastatic, locally advanced or removed with curative intent.
- The sites and volume of cancer before immunotherapy and any residual or treated lesions.
- dMMR/MSI-H status and the specific ICI regimen, duration and reason for stopping or continuing it.
- Changes on previous scans and the direction of CEA results rather than one isolated number.
- Prior surgery, radiation, ablation or other local treatment that can alter how images look.
- New or worsening symptoms, immune-related adverse effects, other illnesses, kidney function and ability to tolerate contrast or a particular scan.
Because these factors can move an appointment earlier or later, a patient should treat the written plan from the oncology team as the operative schedule, not an internet interval detached from the diagnosis.
Questions to take to the next appointment
- What disease setting am I in? Ask whether the plan is for active metastatic disease, surveillance after curative surgery or a defined post-two-year ICI response.
- What is the next test assessing? Clarify whether it is CT, MRI, CEA, a scan to confirm a possible progression or routine surveillance.
- When is the next assessment and why then? Ask how the timing relates to treatment dates, the last scan and any symptoms.
- How will a CEA result be interpreted? Ask what trend would prompt repeat testing, imaging or no change.
- What symptoms should trigger a call before the appointment? Get the team’s preferred contact route and out-of-hours instructions, especially if immunotherapy is ongoing or recently stopped.
- What would change treatment? Knowing in advance whether the team would repeat an equivocal scan, continue treatment, change drugs or consider a local treatment can make the report easier to understand.
When to contact the cancer team sooner
Do not wait for the next scheduled scan to report new, persistent or rapidly worsening symptoms. Contact the oncology service about symptoms such as severe or worsening abdominal pain, persistent diarrhoea, blood in the stool, jaundice, breathlessness, chest pain, confusion, severe weakness, dehydration or a marked change in bowel function. The team can decide whether the symptom is likely to be treatment-related, cancer-related or caused by something else and whether an earlier examination or scan is needed.
Home tumour-marker kits, consumer imaging and supplements are not substitutes for oncology follow-up. The monitoring intervals above come from clinical guidance or a named trial protocol, not from population statistics showing how often every patient is scanned.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
